Silver Oak Securities, Inc Amicus Therapeutics, Inc. Transaction History

Silver Oak Securities, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 20, 2023	SELL	$11.78 - $13.86 $232,054 - $273,028	-19,699 Reduced 95.18%	998 $12,000
Q2 2023 Aug 02, 2023	BUY	$10.72 - $13.3 $35,515 - $44,062	3,313 Added 19.06%	20,697 $259,000
Q1 2023 May 05, 2023	BUY	$10.91 - $13.54 $189,659 - $235,379	17,384 New	17,384 $210,000
Q3 2022 Oct 23, 2023	SELL	$9.82 - $12.75 $193,444 - $251,162	-19,699 Reduced 95.18%	998 $10,000

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

Stay updated on Silver Oak Securities, Inc with notifications on news.